HuagongsheHuagongshe Chemistry Print Report · For research reference only
(2R)-2-(Acetyloxy)propanoyl chloride → (2R)-1-(5-chloro-1-((5-chlorothiazol-2-yl)carbamoyl)spiro[indoline-3,3'-pyrrolidin]-1'-yl)-1-oxopropan-2-yl acetate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (2R)-2-(Acetyloxy)propanoyl chloride | HCID 15557611 | — |
| Reactant | 5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamide | HCID 90449271 | — |
| Product | (2R)-1-(5-chloro-1-((5-chlorothiazol-2-yl)carbamoyl)spiro[indoline-3,3'-pyrrolidin]-1'-yl)-1-oxopropan-2-yl acetate | HCID 89520787 | — |
Reaction Steps
The captioned compound was obtained in the form of a white solid by performing the same reactions and/or treatments as those in Step 1 of Example 17, with the exceptions that (R)-2-acetoxypropionic acid chloride was used instead of acetoxyacetic acid chloride, and that 5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide was used instead of 5-bromo-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08921576B2 |
| Source dataset | uspto-grants-2014_12 |
| ORD ID | ord-03bef8bba67242fc82d9eb31dfb1c50d |
| Source note | uspto-grants-2014_12 |